騰訊(00700.HK)發布首個AI驅動藥物發現平台「雲深智藥」
騰訊(00700.HK)公布,推出人工智能藥物發現平台「雲深智藥」,以協助用戶減少尋找潛在活性藥物的時間和成本。目前平台上運行約10個研發項目,當中包括對抗新冠病毒藥物的虛擬篩選和性質預測,目前篩選得到的化合物正在實驗驗證中。
騰訊首席運營官任宇昕於世界人工智能大會2020雲端峰會開幕式上亦透露,騰訊一直在探索人工智能技術如何應用於輔診、影像、病理等醫療領域,未來平台將全面開放予科研人員使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.